Enhancing diagnosis and treatment of superior cluneal nerve entrapment: cadaveric, clinical, and ultrasonographic insights.
Wei-Ting WuKamal MezianOndřej NaňkaLan-Rong ChenVincenzo RicciChih-Peng LinKe-Vin ChangLevent ÖzçakarPublished in: Insights into imaging (2023)
Ultrasonography effectively localizes SCN branches on the iliac crest, whereby increased nerve CSA is not useful for diagnosis. Most patients benefit from ultrasound-guided dextrose hydrodissection; however, those with scoliosis may experience symptom recurrence and whether structured rehabilitation can reduce recurrence post-injection should be considered as one perspective in future research. Trial registration ClinicalTrials.gov (NCT04478344). Registered on 20 July 2020, https://clinicaltrials.gov/ct2/show/NCT04478344?cond=Superior+Cluneal+Nerve&cntry=TW&draw=2&rank=1 . Critical relevance statement Ultrasound imaging accurately locates SCN branches on the iliac crest, while enlargement of the CSA is not useful in diagnosing SCN entrapment; however, approximately 80% of SCN entrapment cases respond positively to ultrasound-guided dextrose hydrodissection.
Keyphrases
- ultrasound guided
- fine needle aspiration
- end stage renal disease
- peripheral nerve
- ejection fraction
- contrast enhanced
- magnetic resonance imaging
- chronic kidney disease
- newly diagnosed
- computed tomography
- free survival
- peritoneal dialysis
- endovascular treatment
- patient reported
- study protocol
- prognostic factors
- positron emission tomography
- phase iii
- patient reported outcomes
- dual energy
- open label